Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Girges

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Database : the Journal of Biological Databases and Curation|April 3, 2017
Automated PDF highlighting to support faster curation of literature for Parkinson's and Alzheimer's diseaseHonghan Wu, Anika Oellrich, Christine Girges, et al.
Journal of Parkinson'S Disease|September 26, 2022
An Evaluation of KELVIN, an Artificial Intelligence Platform, as an Objective Assessment of the MDS UPDRS Part IIIKrista Sibley, Christine Girges, Joseph Candelario, et al.
Brain : a Journal of Neurology|October 4, 2020
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetesRuth Brauer, Li Wei, Tiantian Ma, et al.
Clinical Trials (London, England)|December 1, 2025
Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseasesChristine Girges, Nirosen Vijiaratnam, Alexa King, et al.
Movement Disorders Clinical Practice|November 20, 2023
Parkinson's Disease Tremor Differentially Responds to Levodopa and Subthalamic StimulationThomas Wirth, Francisca Ferreira, Nirosen Vijiaratnam, et al.
Brain Communications|August 16, 2021
Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson's disease depends on tremor severity and symptom durationNirosen Vijiaratnam, Christine Girges, Thomas Wirth, et al.
Movement Disorders Clinical Practice|August 22, 2024
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification TrialsNirosen Vijiaratnam, Christine Girges, Dilan Athauda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2022
The Impact of Type 2 Diabetes in Parkinson's DiseaseDilan Athauda, James Evans, Anna Wernick, et al.
Journal of Parkinson'S Disease|June 26, 2025
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's diseaseChristine Girges, Alexis de Roquemaurel, Nirosen Vijiaratnam, et al.
Brain Communications|March 5, 2026
Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assayNirosen Vijiaratnam, Christine Girges, Arthur Mitchell, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Database : the Journal of Biological Databases and Curation|April 3, 2017
Automated PDF highlighting to support faster curation of literature for Parkinson's and Alzheimer's diseaseHonghan Wu, Anika Oellrich, Christine Girges, et al.
Journal of Parkinson'S Disease|September 26, 2022
An Evaluation of KELVIN, an Artificial Intelligence Platform, as an Objective Assessment of the MDS UPDRS Part IIIKrista Sibley, Christine Girges, Joseph Candelario, et al.
Brain : a Journal of Neurology|October 4, 2020
Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetesRuth Brauer, Li Wei, Tiantian Ma, et al.
Clinical Trials (London, England)|December 1, 2025
Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseasesChristine Girges, Nirosen Vijiaratnam, Alexa King, et al.
Movement Disorders Clinical Practice|November 20, 2023
Parkinson's Disease Tremor Differentially Responds to Levodopa and Subthalamic StimulationThomas Wirth, Francisca Ferreira, Nirosen Vijiaratnam, et al.
Brain Communications|August 16, 2021
Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson's disease depends on tremor severity and symptom durationNirosen Vijiaratnam, Christine Girges, Thomas Wirth, et al.
Movement Disorders Clinical Practice|August 22, 2024
Exploring Analysis Approaches for Using the Dopamine Transporter Striatal Binding Ratio in Early- to Mid-Stage Parkinson's Disease Modification TrialsNirosen Vijiaratnam, Christine Girges, Dilan Athauda, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2022
The Impact of Type 2 Diabetes in Parkinson's DiseaseDilan Athauda, James Evans, Anna Wernick, et al.
Journal of Parkinson'S Disease|June 26, 2025
Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's diseaseChristine Girges, Alexis de Roquemaurel, Nirosen Vijiaratnam, et al.
Brain Communications|March 5, 2026
Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assayNirosen Vijiaratnam, Christine Girges, Arthur Mitchell, et al.
Pageof 4